Pioneering IVF technique to reduce the risk of children inheriting mitochondrial diseases is being marketed as a fertility procedure for older women, despite little evidence it works. Market analysts and industry participants are closely tracking the development to assess its impact on consumer pricing, liquidity, and domestic business sentiment over the coming quarters.